Maybe a COVID Update5 Jul 2020 18:43
If it happens to be a Covid Update - Hemo CAR T Cells to target Covid 19 then we could see a significant share price.
'Meanwhile, as announced on 22 April 2020, the Company has progressed its work, currently using blood samples from convalescent patients, to attempt to establish why some individuals who are infected with SARS-CoV-2 are asymptomatic, some exhibit mild symptoms, and some become very sick. This work will be of value in developing new forms of treatment, and especially in managing infection risk and assisting individuals better to establish their real risk of getting sick.'